CD Skripsi
Pengaruh Struktur Modal Dan Ukuran Perusahaan Terhadap Profitabilitas Pada Perusahaan Farmasi Yang Terdaftar Di Bei Tahun 2019-2023
Profitability shows how efficiently a company manages its revenues and costs to generate profits. One of the non-oil and gas industry sectors that is the fourth largest contributor to Indonesia and is included in the priorities in the 2015-2035 National Industrial Development Master Plan (RIPIN) for the Indonesian economy is the Chemical, Pharmaceutical and Traditional Medicine Industry. Fluctuations in profitability underlie this study which aims to determine the effect of capital structure and company size on profitability in pharmaceutical companies on the Indonesia Stock Exchange in 2019-2023. The sample used amounted to 9 out of 13 companies. The sampling method used in this study is purposive sampling method. The data analysis technique used is multiple linear regression analysis. The result of this study is the capital structure by Debt to Asset Ratio (DAR) has a negative and insignificant effect on profitability with a coefficient value of -0.203 < t table 2.02108 and sig value. 0.840 > 0.05 and the capital structure by Debt to Equity Ratio (DER) has a negative insignificant negative effect on profitability with a coefficient of -0.210 < t table 2.02108 and sig value. 0,834 > 0,05. Company size by LnTA has a significant negative effect on profitability with LnTA coefficient value of -2.270 < t table 2.02108 and sig value. 0.029 < 0.05 and LnTP has an insignificant positive effect with its coefficient value of 0.413 < t table 2.02108 and sig value. 0,682 > 0,05. The coefficient value of 0.362 = 36.2% of capital structure and company size has a relationship to profitability and R² value of 0.131 = 13.1% means that profitability can be explained by capital structure and company size only 13.1% using these ratios.
Keywords: capital structure, company size, profitability.
Tidak tersedia versi lain